Real-time enrollment status for this diffuse large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:34 AM UTC
| NCT Number | NCT02227251 |
| Recruiting Status | Recruiting |
| Condition | Diffuse Large B-Cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 244 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Karyopharm Therapeutics Inc |
| Last Updated on CT.gov | October 1, 2025 (Oct 1, 2025) |
As of March 2, 2026: Clinical trial NCT02227251 is currently recruiting participants. This clinical trial study for diffuse large b-cell lymphoma is actively seeking new participants at 23 locations across the United States. The study is sponsored by Karyopharm Therapeutics Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02227251 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02227251 was last updated Oct 1, 2025 (October 1, 2025). HelloStudys verifies this status automatically.